Up a level |
Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2021) The COVID-19 innovation system. Health Affairs, 40 (3). 400 - 409. ISSN 0278-2715
Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835, Sampat, Bhaven N. and Kapczynski, Amy (2020) Patents, trade, and medicines: past, present, and future. Review of International Political Economy, 27 (1). 75 - 97. ISSN 0969-2290
Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 and Sampat, Bhaven N. (2018) Indian pharmaceutical patent prosecution: the changing role of Section 3(d). PLOS ONE, 13 (4). ISSN 1932-6203
Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2017) Secondary pharmaceutical patenting: a global perspective. Research Policy, 46 (3). pp. 693-707. ISSN 0048-7333
Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2015) Drug patenting in India: looking back andlooking forward. Nature Reviews: Drug Discovery, 14. pp. 519-520. ISSN 1474-1776
Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2015) TRIPS implementation and secondary pharmaceutical patenting in Brazil and India. Studies in Comparative International Development, 50 (2). pp. 228-257. ISSN 0039-3606
Sampat, Bhaven N., Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 and Amin, Tahir M. (2012) Challenges to India's pharmaceutical patent laws. Science, 337 (6093). pp. 414-415. ISSN 0036-8075
Kapczynski, Amy, Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2017) Trade agreements, patents, and drug prices: continuing the debate. Research Paper (572). John M. Olin Center for Studies in Law, Economics, and Public Policy, Yale Law School, New Haven, CT.
Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 and Sampat, Bhaven N. (2015) Drug patenting in India: looking back and looking forward. South Asia @ LSE (09 Nov 2015). Blog Entry.
Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835, Sampat, Bhaven N. and Amin, Tahir M. (2012) Balancing innovation and access: India’s pharmaceutical patent laws. (23 Jul 2012). Website.